At least four of six different vaccine candidates financially backed by the U.S. government aimed at the novel coronavirus are predicted to fail in the clinic, according to a draft report from an analytics group cited by CNBC.
https://www.pharmalive.com/wp-content/uploads/2020/09/At-Least-4-Vaccine-Candidates-Backed-by-U.S.-Government-Predicated-to-Fail-Analytics-Group-Says-BioSpace-9-2-20.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2020-09-02 12:04:582020-09-02 21:53:50At Least 4 Novel Coronavirus Vaccine Candidates Backed by U.S. Government Predicated to Fail, Analytics Group Says